Zycus Named a LEADER in 2025 IDC MarketScape for Source-to-Pay
Zycus, a global leader in AI-powered procurement technology, has been named a Leader in the IDC MarketScape: Worldwide AI-Enabled Source-to-Pay 2025 Vendor Assessment.
This recognition follows a comprehensive evaluation, including RFI submissions, live product demos, analyst briefings, and customer interviews.
“Zycus is a recognized Leader in the Source-to-Pay space leveraging Agentic AI to drive procurement transformation. With AI agents like Merlin Intake and the Autonomous Negotiation Agent (ANA), Zycus offers a seamlessly integrated solution suite for enterprises focused on cost savings, risk mitigation, and scalability,”
— Patrick Reymann, Research Director, IDC
“We believe this recognition underscores our commitment to empowering procurement teams through Merlin Agentic Platform, deep domain expertise, and customer-first innovation,” said Aatish Dedhia, Founder & CEO, Zycus. “With a global product footprint spanning every aspect of the S2P lifecycle, Zycus is proud to support enterprises worldwide in achieving procurement excellence.”
The report acknowledges Zycus’s strengths in:
- AI-Driven Automation and Compliance: Zycus leverages GenAI, Agentic AI and advanced automation to streamline invoice-to-PO, contract, and receipt validation, supporting 2-way, 3-way, and 4-way matching. The platform’s AI-driven anomaly detection flags pricing mismatches, duplicate invoices, and policy violations, enhancing compliance and reducing manual intervention.
- Customer Support: Users express broad satisfaction with customer support and find the Zycus support infrastructure to be responsive and attentive. Zycus' Voice of theCustomer program is an innovative approach that drives actionable insights to shape product development.
The report further states:
“Buyers should consider Zycus when seeking a mature, AI-powered, and forward-thinking S2P platform that delivers robust automation, compliance, and supplier collaboration. Zycus is particularly well-suited for mid-sized to large multinational organizations aiming to digitize procurement, enforce policy compliance, and drive efficiency across the full S2P lifecycle.”
Integrated Source-to-Pay Platform
Zycus provides a modular suite covering procurement, eInvoicing, spend analysis, supplier and contract management, and sourcing. The platform integrates seamlessly with leading ERP and finance systems, offering bi-directional sync and customizable workflows.
For more information on Zycus’ Source-to-Pay Suite and its position in IDC MarketScape, click here.
About IDC MarketScape
IDC MarketScape’s vendor assessment model is designed to provide an overview of the competitive fitness of technology and service providers in a given market. The research methodology employs a rigorous scoring system based on both qualitative and quantitative criteria, resulting in a single graphical illustration of each vendor’s position.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250702493109/en/
Contacts
Pooja Newar
Senior Marketing Manager
Pooja.newar@zycus.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Tecnotree Recognized in Two 2025 Gartner ® Hype Cycle™ Reports7.7.2025 17:46:00 EEST | Press release
Tecnotree, a global digital platform and services leader for AI, 5G, and cloud-native technologies, has been recognized in two 2025 Gartner® Hype Cycle™ reports. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250707226738/en/ Tecnotree Recognized in Two 2025 Gartner® Hype Cycle™ Tecnotree has been recognized in the following 2025 Gartner Hype Cycle reports: Hype Cycle for Enterprise Communication Services, 2025 for CSP Digital MarketplacesHype Cycle for Operations and Automation in the Communications Industry, 2025 for Partner Ecosystem Management Platforms for CSPs and AI for CSP Customer Interactions We believe that this recognition highlights Tecnotree’s commitment to accelerating CSPs’ digital transformation journeys by offering composable, AI-driven solutions that enable ecosystem monetization, automated customer interactions, and next-gen partner management. These capabilities are part of the Tecnotree Moments and Tecn
Kevin Egan Joins ClickHouse as Chief Revenue Officer to Accelerate Growth7.7.2025 16:00:00 EEST | Press release
ClickHouse, a leader in real-time analytics, data warehousing, observability, and AI/ML, today announced the appointment of Kevin Egan as Chief Revenue Officer (CRO). With over two decades of experience building and leading enterprise sales organizations at Atlassian, Slack, Dropbox, and Salesforce, Egan will oversee ClickHouse’s global go-to-market functions as demand continues to grow. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250707959780/en/ Aaron Katz, ClickHouse CEO with Kevin Egan, ClickHouse CRO “I’m incredibly excited to join ClickHouse at such a pivotal time,” said Egan. “As organizations navigate how to compete and thrive in the AI era, ClickHouse is emerging as the de facto database powering the real-time, scalable analytics that AI-driven applications demand. I look forward to building strong relationships not only with forward-thinking customers, but also with our channel and technology partners—working to
Accellix Appoints Dr. Félix A. Montero-Julian as Vice President of Scientific Affairs7.7.2025 15:00:00 EEST | Press release
Accellix, a global leader in rapid point of need cytometry solutions, is pleased to announce the appointment of Félix A. Montero-Julian, PhD as Vice President of Scientific Affairs. Dr. Montero-Julian brings more than 30 years of international experience in scientific affairs, analytical development, and regulatory science to support Accellix’s strategic vision and innovation roadmap. Dr. Montero-Julian joins Accellix from bioMérieux, where he most recently served as Scientific Senior Director of Pharma Quality Control. His previous roles include Cytometry R&D Director at bioMérieux and Director of the Cellular Analysis Department at Beckman Coulter, underscoring a distinguished track record spanning biopharmaceuticals, industrial microbiology, and clinical diagnostics. “I’m excited to join Accellix during this period of dynamic growth and innovation,” said Dr. Montero-Julian. “I have great confidence in the potential of the Accellix Platform to transform quality control in cell and ge
NTT DATA Appoints Anne-Sophie Lotgering as Europe CEO7.7.2025 14:00:00 EEST | Press release
NTT DATA, a global leader in digital business and technology services, today announced the appointment of Anne-Sophie Lotgering as the new Chief Executive Officer for Europe at NTT DATA, Inc., effective 1 September 2025. Lotgering succeeds Chieri Kimura and will report directly to NTT DATA, Inc. President and Global CEO, Abhijit Dubey. She will also join NTT DATA, Inc.’s Executive Leadership Team. Lotgering brings over two decades of leadership experience in IT services and telecommunications, with a strong track record in B2B2C and B2B sales, digital marketing and transformation. She joins NTT DATA from Proximus NXT IT where she served as CEO, overseeing the IT integration of B2B operations across the Netherlands, Luxembourg, and Belgium. Her recent achievements include the successful unification of multiple subsidiaries into a single, agile organization, strategically aligned with high-growth sectors such as cloud, cybersecurity and data. Her career spans senior roles at The Orange G
CorFlow Therapeutics Announces FDA Approval of the MOCA-II IDE Pivotal Trial to Validate a Novel Heart Attack Care Technology7.7.2025 14:00:00 EEST | Press release
CorFlow Therapeutics AG (CorFlow), a pioneering company in the field of cardiac care targeting microvascular disease, today announced that the U.S. Food & Drug Administration (FDA) has approved the company’s technology for investigational device exemption (IDE), which allows the pivotal clinical trial to begin at U.S. hospitals. CorFlow will now prepare these clinical trial sites to receive CorFlow systems, undergo training and begin enrolling patients being treated for heart attacks. The IDE Pivotal Trial, MOCA-II, is intended to prospectively validate the diagnostic accuracy of the proprietary CorFlow CoFl system in determining the presence or absence of microvsacular obstruction (MVO) during a primary PCI procedure. The primary endpoint compares the CoFI diagnostic reading to a reference standard of diagnosis by a cardiac MRI scan. The trial is approved to enroll over 200 STEMI patients at prestigious research institutions in both the United States and Europe. Having successfully co
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom